Persist AI vs Amazon
Side-by-side comparison of AI visibility scores, market position, and capabilities
AI-powered long-acting injectable drug formulation platform cutting development from 5 years to 2; $12M Series A with Eli Lilly investment competing in microsphere CDMO development.
About
Persist AI is a pharmaceutical formulation company operating an AI-powered drug formulation platform with robotic cloud lab capabilities — specializing in the development of long-acting injectable (LAI) microsphere formulations that can deliver drug release over weeks or months (up to one year), addressing the adherence challenges of daily oral medications for chronic conditions including mental health, addiction, HIV, contraception, and oncology. Founded in 2022 and backed by $16 million including a $12 million Series A led by Spero Ventures with participation from Eli Lilly, Persist AI accelerates drug development timelines by approximately 50%, reducing typical 5-year formulation development to 2 years.\n\nPersist AI's platform combines AI-driven formulation design (predicting which polymer/drug/process combinations will achieve target release profiles) with robotic laboratory execution (automated synthesis and testing of formulation candidates) and analytics that identify optimal formulations faster than traditional trial-and-error approaches. The microsphere technology encapsulates drug molecules in biodegradable polymer spheres that gradually release the drug as the polymer degrades — a proven technology (Risperdal Consta, Lupron Depot) but one that takes years to develop with traditional methods. Eli Lilly's participation as an investor signals pharma validation of the platform approach.\n\nIn 2025, Persist AI competes in the drug formulation and CDMO (contract development and manufacturing) market with EVO Pharma, Polymeropoulos (a long-acting injectable specialist), and larger CDMOs including Lonza and Catalent for LAI microsphere development services. The long-acting injectable market is growing as mental health conditions (schizophrenia, bipolar) see improved outcomes with LAI antipsychotics that eliminate the adherence problem — patients who receive monthly or quarterly injections have significantly better medication compliance than those taking daily pills. The 2025 strategy focuses on growing pharma company partnerships for LAI development projects, advancing internal pipeline candidates toward clinical trials, and building the manufacturing scale-up capabilities needed for commercial supply.
Amazon (AMZN) reported $638B revenue in FY2024, up 11% YoY. AWS revenue $105.3B (+19%). Market cap ~$2.2T. 1.5M+ employees. Seattle, WA. AWS is world's largest cloud provider. Bedrock AI platform, custom Trainium chips.
About
Amazon was founded in 1994 by Jeff Bezos in Bellevue, Washington as an online bookstore operating from a garage, with the stated ambition of becoming "the everything store" — a long-term vision that proved accurate well beyond what even early investors anticipated. Bezos's founding philosophy centered on customer obsession, long-term thinking, and a willingness to invest in infrastructure years before it would generate returns. The company went public in 1997 and systematically expanded from books into electronics, then general merchandise, then marketplace third-party selling, and ultimately into cloud computing, digital media, devices, logistics, and healthcare. Amazon Web Services, launched in 2006, was a consequence of the internal infrastructure Amazon had built to scale its retail operations — and became the company's most profitable business.\n\nAmazon operates one of the most complex multi-business enterprises in corporate history. Amazon.com and its marketplace of 2+ million third-party sellers represent the world's largest e-commerce platform. AWS serves as the cloud infrastructure backbone for a substantial portion of the global internet, generating $105.3 billion in revenue in FY2024. Amazon Prime, with hundreds of millions of members globally, bundles shipping benefits, streaming video, music, gaming, and pharmacy services into a loyalty flywheel that increases purchase frequency and customer lifetime value. Additional major business lines include Alexa and Echo devices, Kindle and digital content, Amazon Advertising (a $56B+ revenue business), Whole Foods, Amazon Pharmacy, and Amazon Logistics.\n\nAmazon reported FY2024 revenue of $638 billion, up 11% year over year, with a market capitalization of approximately $2.2 trillion — making it one of the five most valuable companies globally. The company employs 1.5 million+ people worldwide, making it one of the largest private employers on earth. Andy Jassy, who built AWS from its founding and succeeded Bezos as CEO in 2021, has focused Amazon's strategy on AWS AI infrastructure, advertising growth, and logistics efficiency as the primary drivers of long-term margin expansion.
AI Visibility Head-to-Head
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.